In human liver, farnesoid X receptor (FXR) negatively regulates lipid synthesis and mice lacking FXR are more susceptible to develop NASH probably due to the induction of the inflammatory and fibrogenic response mediated by NF-κB signaling pathway. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.